Elisabetta Rovida Selected Research

Reactive Oxygen Species (Oxygen Radicals)

1/2022

MAPK15 protects from oxidative stress-dependent cellular senescence by inducing the mitophagic process.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elisabetta Rovida Research Topics

Disease

19	Neoplasms (Cancer) 05/2022 - 01/2011
11	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2022 - 02/2011
7	Leukemia 10/2018 - 05/2007
7	Hypoxia (Hypoxemia) 01/2017 - 05/2007
6	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2013
5	Melanoma (Melanoma, Malignant) 05/2024 - 01/2014
5	Residual Neoplasm 08/2021 - 01/2014
4	Inflammation (Inflammations) 01/2023 - 03/2008
4	Cholangiocarcinoma 10/2021 - 01/2019
2	Liver Neoplasms (Liver Cancer) 01/2022 - 02/2015
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2013 - 12/2003
1	Endometriosis 01/2023
1	Bullous Pemphigoid (Pemphigoid) 01/2023
1	Carcinogenesis 01/2023
1	Fibrosis (Cirrhosis) 04/2022
1	Alcoholic Fatty Liver 04/2022
1	Cicatrix (Scar) 04/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Oncogene Addiction 01/2017
1	Ascites 01/2016
1	Ischemia 01/2014
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2014
1	Chronic Disease (Chronic Diseases) 01/2014
1	Genomic Instability 01/2013
1	Breast Neoplasms (Breast Cancer) 01/2011
1	Acute Erythroblastic Leukemia (Erythroleukemia) 05/2007

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 05/2024 - 02/2011
7	Mitogen-Activated Protein KinasesIBA 05/2024 - 09/2015
6	Oxygen (Dioxygen)IBA 08/2021 - 05/2007
5	Mitogen-Activated Protein Kinase 7IBA 05/2024 - 10/2018
5	Tyrosine Kinase InhibitorsIBA 08/2021 - 01/2014
5	Imatinib Mesylate (Gleevec)FDA Link 10/2020 - 02/2011
3	XMD 8-92IBA 05/2024 - 09/2015
3	Messenger RNA (mRNA)IBA 05/2024 - 02/2011
3	Glucose (Dextrose)FDA LinkGeneric 01/2014 - 02/2011
2	LipidsIBA 01/2023 - 04/2015
2	Glutamine (L-Glutamine)FDA Link 08/2021 - 01/2014
2	Histones (Histone)IBA 02/2013 - 12/2003
2	Macrophage Colony-Stimulating FactorIBA 01/2011 - 03/2008
1	Carrier Proteins (Binding Protein)IBA 05/2024
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2024
1	Conditioned Culture MediaIBA 05/2024
1	AntibodiesIBA 05/2024
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2023
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2023
1	AntioxidantsIBA 01/2023
1	AutoantibodiesIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	LigandsIBA 01/2023
1	SphingolipidsIBA 01/2023
1	IntegrinsIBA 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 05/2022
1	c-Mer Tyrosine KinaseIBA 04/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2022
1	Mitogen-Activated Protein Kinase 3IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	GalactosidasesIBA 01/2022
1	Cyclin-Dependent Kinase Inhibitor p21IBA 01/2022
1	JNK Mitogen-Activated Protein KinasesIBA 01/2022
1	Small Interfering RNA (siRNA)IBA 10/2021
1	GoldIBA 02/2021
1	ponatinibIBA 10/2020
1	Casein Kinase II (Casein Kinase 2)IBA 10/2019
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 10/2019
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 10/2019
1	derazantinibIBA 10/2019
1	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2019
1	ChemokinesIBA 01/2019
1	VemurafenibIBA 01/2018
1	Oxidoreductases (Dehydrogenase)IBA 02/2017
1	dihydrofolateIBA 02/2017
1	5,6,7,8-tetrahydrofolic acid (tetrahydrofolate)IBA 02/2017
1	Methotrexate (Mexate)FDA LinkGeneric 02/2017
1	AcriflavineIBA 01/2017
1	bcr-abl Fusion ProteinsIBA 01/2017
1	Epidermal Growth Factor (EGF)IBA 09/2015
1	ProstaglandinsIBA 06/2015
1	Dinoprostone (PGE2)FDA Link 06/2015
1	GTP-Binding Proteins (G-Protein)IBA 06/2015
1	ChromatinIBA 02/2015
1	Cysteine Proteases (Cysteine Protease)IBA 02/2015
1	Pyruvic Acid (Pyruvate)IBA 01/2014
1	Histone Deacetylase InhibitorsIBA 02/2013
1	Vorinostat FDA Link 02/2013
1	CarcinogensIBA 01/2013
1	Transcription Factors (Transcription Factor)IBA 01/2013
1	o-AminoazotolueneIBA 01/2013
1	Bortezomib (Velcade)FDA Link 02/2011
1	Cyclin D1IBA 01/2011
1	Core Binding Factors (Core-Binding Factor)IBA 12/2003
1	Butyrates (Butyrate)IBA 12/2003

Therapy/Procedure

11	Therapeutics 01/2023 - 01/2011
3	Immunotherapy 05/2024 - 04/2015
1	Drug Therapy (Chemotherapy) 10/2021
1	Subcutaneous Injections 10/2021
1	Precision Medicine 02/2021